Investor Presentaiton
Accelerate Life-Saving Treatments
■ With a foundation as the leading, global provider of research models, we have
built upon this legacy to develop a diverse portfolio of products and services
that spans discovery, non-clinical development, and manufacturing
■ Serve as an indispensable partner to our clients, providing scientific expertise
and collaboration to support research at every point along the drug continuum
■ Providing a broad portfolio and global scale allows clients to enhance their
productivity and effectiveness, while lowering costs and increasing speed to
market
☐
■ Commit to transforming the drug development process and delivering
innovative, safe, and effective treatments to patients faster
Innovate scientifically and technologically to achieve our goal of further
reducing our clients' drug development timelines
Every Moment Matters
CRL has worked on
>80%
of drugs approved by
the U.S. Food and Drug
Administration (FDA)
over the last 5 years
10+
Average number of
years to develop a new
therapeutic
~$2.5B
Average cost to
research and develop
each successful drug
Charles River Laboratories (CRL)
3View entire presentation